Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 719 results for "zydus cadila"

Zydus to sell Asacol HD's generic in US market
Money Control

Zydus To Sell Ulcerative Colitis Treatment Generic Drug In US ...

Representational image New Delhi : Drug firm Cadila Healthcare's USarm Zydus Pharmaceuticals (USA) Inc will start selling ageneric version of Asacol HD, used for treatment of ulcerativecolitis, in the American market from August 1, 2016. ... NDTV, 1 week ago
Zydus to sell Asacol HD's generic in US market Business Standard, 1 week ago

44 images for zydus cadila

Money Control, 2 weeks ago
Business Standard India, 2 weeks ago
Business Standard India, 1 month ago
VC Circle, 1 month ago
First Post.com, 2 weeks ago
Financial Express, 2 weeks ago
Pharmafile, 2 weeks ago
Pharma Letter, 1 month ago
India Infoline, 2 weeks ago
Hindu Business Line, 2 weeks ago
Business Standard India

CADILA HEALTHCARE : Fda nod for zydus' anti-diabetic drug

Cadila Healthcare Ltd (Zydus Cadila) has received the approval of the US Food and Drug Administration (FDA) for its anti-diabetic drug. The company will market Nateglinide tablets in strengths of 60 mg and 120 mg in the US. Cadila intends to ...
 4 Traders2 weeks ago Zydus receives US FDA approval for anti-diabetic drug Nateglinide tablets USP  PharmaBiz2 weeks ago Cadila Healthcare jumps 4%; sees US and LatAm as key markets  India Infoline2 weeks ago Zydus gets FDA nod for diabetes drug  Business Standard India2 weeks ago
[x]  
VC Circle

Zydus Wellness steps on gas: plans Everyuth re-launch, eyes buy-outs

The Rs 429-crore personal care arm of Ahmedabad-based pharmaceutical giant Cadila Healthcare, Zydus Wellness Ltd, which has been clocking a 3-4 per cent compounded growth rate in revenues for the past few years, has drawn up plans to propel the ...
 Smart Investor4 weeks ago Indian firm Zydus Cadila purchases two ANDAs from Teva  Pharmaceutical Technology1 month ago Cadila to acquire two drug forms from Teva to strengthen its US portfolio  Domain-B1 month ago Zydus Cadila acquires two drugs from Teva to strengthen US portfolio  VC Circle1 month ago
[x]  
Financial Express

Lupin, 5 Other Pharma Firms Ink Licensing Pact With Medicines Patent Pool

New Delhi : Indian pharma firms Aurobindo, Emcure, Hetero Labs, Laurus Labs, Lupin and Zydus Cadila are among the seven drug makers which have signed licensing pact with UN-backed Medicines Patent Pool (MPP) for producing HIV and hepatitis C drugs. ...
 NDTV2 weeks ago 6 Indian pharma cos ink licensing pact with UN-backed MPP  Business Standard2 weeks ago Zydus inks pact with Medicines Patent Pool for HepatitisC drug  Business Standard2 weeks ago Zydus Cadila inks pact with Medicines Patent Pool for Hepatitis C drug  Pharmaceutical Tech.com2 weeks ago
[x]  
Business Standard India

Zydus Cadila partners with Eczacibasi to tap Turkish biosimilar market

As per the deal, Zydus will market biosimilars, which are currently unavailable in Turkey especially for the treatment of cancer BS B2B Bureau | Ahmedabad June 16, 2016 Last Updated at 15:04 IST The Ahmedabad-based Zydus Cadila yesterday signed a ...
 Business Standard India1 month ago Zydus Cadila inks strategic collaboration to market biosimilars in Turkey  Pharma Letter1 month ago India's Zydus Cadila and Eczacibasi to market biotech products in Turkey  CPhI.cn1 month ago Zydus Cadila collaborates with Eczacibasi Ilac Pazarlama Aims to increase reach in Turkish market via biosimilars & new products  EHealth Magazine1 month ago
[x]  
Business Line

Zydus and MPP sign sub-licence agreement for BMS Hepatitis medicine

Indian-based pharmaceutical company Zydus Cadila has signed a non-exclusive, royalty-free agreement with the Medicines Patent Pool (MPP), a UN-backed organisation in Switzerland, for the generic production of Bristol-Myers Squibb's daclatasvir to ...
 CPhI.cn2 weeks ago Zydus enters into a sub-licensing agreement with The Medicines Patent Pool for Hepatitis C Medicine, daclatasvir  Equity Bulls2 weeks ago Zydus inks sub-licensing agreement with MPP for hepatitis medicine  Business Line2 weeks ago Cadila up 4% on sub-licensing agmt with UN health organisation  Money Control2 weeks ago
[x]  

Zydus Cadila to present new scientific data on Saroglitazar at annual scientific sessions of ADA

Zydus Cadila announced that new data on Saroglitazar have been selected for presentations at the 76th Annual Scientific Sessions of the American Diabetes Association (ADA) in New Orleans, Louisiana, USA from 10-14 June, 2016. Real-world patient ...
 PharmaBiz1 month ago Cadila's new data on Saroglitazar to be presented at ADA  HT Syndication1 month ago New Scientific Data of Investigational Lipaglyn[TM] (Saroglitazar), and Real World Data in Patients will be Featured at American Diabetes Association (ADA) 76th Scientific Sessions  Bloomberg1 month ago Zydus Cadila to present new data on Saroglitazar at ADA  Equity Bulls1 month ago
[x]  
India Infoline

Zydus to sell biosimilars in Turkey

Healthcare provider Zydus Cadila, on Wednesday, announced the signing of a collaboration agreement with Turkeys Eczacibasi Ilac Pazarlama, A.S., to market biotech products in the Turkish market. The agreement involves import of biosimilars which are currently ...
 Business Line1 month ago Zydus teams up with Eczacibasi Ilac to market biosimilars in Turkey  Business Line1 month ago NPPA cuts antibiotic, stomach ulcer and abortion drug prices by 30%  Economic Times2 months ago
Livemint.com

MPP inks new round of generic manufacturing licences for HIV, hepatitis C treatments; Zydus Cadila new partner

The Medicines Patent Pool (MPP) announced new generic manufacturing licences for four antiretrovirals and hepatitis C direct-acting antiviral daclatasvir. The organisation signed licences with Aurobindo, Desano, Emcure, Hetero Labs, Laurus Labs, ...
 PharmaBiz2 weeks ago The Medicines Patent Pool Signs New Round of Generic Manufacturing Licences for HIV and Hepatitis C Treatments  TickerTech.com2 weeks ago MPP IN PACT TO MANUFACTURE HIV, HEPATITIS C DRUGS  Pharmacy Choice1 week ago Medicines Patent Pool expands HIV, hep C generic licenses  FiercePharma2 weeks ago
[x]  

Zydus Cadila standalone net down marginally at Rs 338 cr in Q4

Healthcare player, Cadila Healthcare (Zydus Cadila), posted a standalone net profit of Rs 338 crore in the quarter ended March 2016, which is a marginal decline of 2 per cent on the Rs 347 crore posted in the corresponding quarter a year ago. The company's ...
 Business Line2 months ago Cadila Q4 net up 11% to Rs 389 cr; to raise up to Rs 18,500 cr  Business Standard2 months ago Cadila Healthcare plans to raise funds through securities  The Hindu2 months ago Cadila Healthcare plans to raise Rs 18,500 cr  Business Line2 months ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - zydus cadila
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less